• OPEN AN ACCOUNT
Indian Indices
Nifty
25,330.25 91.15
(0.36%)
Sensex
83,018.97 325.26
( 0.39%)
Bank Nifty
55,493.30 345.70
( 0.63%)
Nifty IT
36,447.15 235.00
( 0.65%)
Global Indices
Nasdaq
46,015.42 236.51
(0.52%)
Dow Jones
6,617.88 9.88
(-0.15%)
Hang Seng
45,342.39 552.01
(1.23%)
Nikkei 225
9,208.37 12.71
(0.14%)
Forex
USD-INR
88.02 0.00
(0.00%)
EUR-INR
104.02 0.00
(0.00%)
GBP-INR
120.02 0.00
(0.00%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531752
INE703D01023
1.0882714
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
90
81.23
EPS(TTM)
Face Value()
Div & Yield %
0.01
1
0
 

infosys ltd
Biogen Pharmachem Industries standalone net profit rises 59.46% in the March 2025 quarter
May 24,2025
Net profit of Biogen Pharmachem Industries rose 59.46% to Rs 1.18 crore in the quarter ended March 2025 as against Rs 0.74 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.29 crore in the year ended March 2025 as against net profit of Rs 1.93 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.